In Silico Analysis of Possible microRNAs Involved in the Pathogenesis of White-Nose Syndrome in Myotis lucifugus

Anouska Agarwal1, Craig K R Willis1, Anuraag Shrivastav1,2

  • 1Department of Biology, The University of Winnipeg, Winnipeg, MB R3B 2E9, Canada.

Insights

MicroRNAs (miRNAs) may help bats survive white-nose syndrome (WNS) by regulating fat and immune pathways. Specific miRNAs were detected in bats, suggesting their potential as biomarkers for WNS survival.

Area of Science:

  • Veterinary Medicine
  • Molecular Biology
  • Ecology

Background:

  • White-nose syndrome (WNS), caused by *Pseudogymnoascus destructans*, has led to significant bat mortality in North America.
  • Bats surviving WNS, like the little brown bat (*Myotis lucifugus*), exhibit increased pre-hibernation fat reserves, potentially aiding survival.
  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression and are implicated in metabolic and immune functions.

Purpose of the Study:

  • To investigate the role of differentially expressed miRNAs in bat survival of WNS.
  • To identify specific miRNAs involved in metabolic and immune pathways crucial for WNS pathogenesis.
  • To evaluate the potential of selected miRNAs as biomarkers for WNS pathophysiology and survival.

Main Methods:

  • Bioinformatic analysis (DIANA Tools, KEGG) of 43 previously identified differentially expressed miRNAs.
  • Identification of miRNAs regulating key WNS-related pathways, including immune response, lipogenesis, insulin signaling, and FOXO signaling.
  • Quantification of selected miRNA prevalence in plasma samples from bats using reverse transcription quantitative real-time PCR (RT-qPCR).

Main Results:

  • Four miRNAs (miR-543, miR-27a, miR-92b, miR-328) were identified as key regulators of WNS-relevant pathways.
  • These selected miRNAs were detectable in plasma samples of bats from a post-WNS population during fall fattening.
  • Prevalence of these miRNAs varied among individuals, indicating potential differences in physiological status.

Conclusions:

  • Selected miRNAs show promise as potential biomarkers for assessing WNS pathophysiology and survival in bats.
  • Further in vivo studies are warranted to confirm the functional roles and biomarker utility of these miRNAs.
  • Understanding miRNA regulation of metabolism and immunity could offer new insights into bat resilience against WNS.